Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT02624596
PHASE2

Understanding How Ketamine Brings About Rapid Improvement in OCD

Sponsor: Stanford University

View on ClinicalTrials.gov

Summary

The purpose of this study is to understand how ketamine brings about rapid improvement in Obsessive-Compulsive Disorder (OCD) symptoms.

Official title: NMDAR Modulation As a Therapeutic Target and Probe of Neural Dysfunction in OCD

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

120

Start Date

2016-08-16

Completion Date

2021-06-28

Last Updated

2026-08-13

Healthy Volunteers

Yes

Interventions

DRUG

Ketamine

OCD patients in this arm will receive 0.5mg/kg of ketamine - one single infusion

DRUG

Midazolam

OCD patients in this arm will receive 0.045mg/kg of midazolam - one single infusion

Locations (1)

Stanford University

Stanford, California, United States